ViaDerma/ US92555K1016 /
2024-04-19 9:10:22 PM | Chg. +0.0003 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.0098USD | +3.10% | 457,420 Turnover: 4,283.6940 |
-Bid Size: - | -Ask Size: - | 0.0098 | 0.0090 |
GlobeNewswire
2023-10-24
ViaDerma Update on Stability Testing, Global Sales Distribution, National Licensing, Nupelo & More
GlobeNewswire
2021-10-04
ViaDerma, Inc. Set to Launch Two New and Improved Versions of its Flagship Product, Vitastem and Vit...
GlobeNewswire
2021-06-02
ViaDerma, Inc. Announces Expansion of its Current Licensing Agreement and Provides Additional Compan...
GlobeNewswire
2021-04-08
ViaDerma, Inc. Provides Preliminary Revenue Estimates and Highlights for its Record Breaking 1st Qua...
GlobeNewswire
2021-03-16
ViaDerma, Inc. Announces the Payment of all Toxic Convertible Notes and Has Become Debt Free
GlobeNewswire
2021-01-21
ViaDerma, Inc. Completes a Licensing Agreement with a Group of Affiliate Wound Care Medical Practice...
GlobeNewswire
2018-05-29
ViaDerma Announces Increase of Amazon Sales on the Heels of U.S. Department of Commerce Trade Missio...
GlobeNewswire
2018-05-15
United States Commerce Department Invites ViaDerma to Participate in Official Trade Mission to India
GlobeNewswire
2018-04-24
ViaDerma, Inc. Enters into a $250,000 Initial Sales Agreement with Vage Nigeria Ltd.
GlobeNewswire
2018-02-07
ViaDerma, Inc. Announced the Dismissal of a Lawsuit Against Them in US District Federal Court